Kennedy Capital Management, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Kennedy Capital Management, Inc.
- $4.23 Billion
- Q4 2024
A detailed history of Kennedy Capital Management, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 5,156 shares of REGN stock, worth $2.9 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
5,156
Previous 4,504
14.48%
Holding current value
$2.9 Million
Previous $4.73 Million
22.43%
% of portfolio
0.09%
Previous 0.11%
Shares
4 transactions
Others Institutions Holding REGN
# of Institutions
1,497Shares Held
87MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$5.23 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.76 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$3.98 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.72 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$2.67 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $60.4B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...